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Background: Hypothermia in the perioperative period is associated with
adverse effects, particularly bleeding. Before termination of cardiopul-
monary bypass, rewarming times and perfusion temperatures are often
increased to avoid post–cardiopulmonary bypass hypothermia and the
presumed complications. This practice may, however, also have adverse
effects, particularly cerebral hyperthermia. We present safety outcomes
from a trial in which patients undergoing coronary artery surgery were
randomly assigned to normothermia or hypothermia for the entire surgi-
cal procedure.
Methods: Consenting patients over the age of 60 years presenting for a
first, elective coronary artery surgery with cardiopulmonary bypass were
randomly assigned to having their nasopharyngeal temperature maintained at either
37°C (group N; 73 patients) or 34°C (group H; 71 patients) throughout the intra-
operative period, with no rewarming before arrival in the intensive care unit. All
received tranexamic acid.
Results: There was no clinically important difference in intraoperative blood prod-
uct or inotrope use. Temperatures on arrival in the intensive care unit were 36.7°C
 0.38°C and 34.3°C  0.38°C in groups N and H, respectively. Blood loss during
the first 12 postoperative hours was 596  356 mL in group N and 666  405 mL
in group H (mean difference  95% confidence interval, 70  126 mL; P  .28).
There was no significant difference in blood product utilization, intubation time,
time in the hospital, myocardial infarction, or mortality. The mean time in the
intensive care unit was 8.4 hours less in the hypothermic group (P  .02).
Conclusions: Our data support the safety of perioperative mild hypothermia in
patients undergoing elective nonreoperative coronary artery surgery with cardiopul-
monary bypass. These findings suggest that complete rewarming after hypothermic
cardiopulmonary bypass is not necessary in all cases.
Adverse effects of hypothermia are an important concern in surgicalpatients, with an expanding literature documenting complications,particularly bleeding, when body temperature is not maintained at36°C in the perioperative period.1 Hypothermia has, however,been shown to be neuroprotective in laboratory studies, as well asin 2 recent randomized clinical trials of survivors of out-of-
hospital cardiac arrest.2,3 These findings encourage clinical trials of mild hypother-
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mia in other populations of patients at risk of cerebral
injury.4 Although there are numerous trials of cardiopulmo-
nary bypass (CPB) at warm and cold temperatures,5,6 in all
studies patients are rewarmed to at least 36°C before sepa-
ration from CPB. The reluctance to separate from CPB at
hypothermic temperatures is likely due to the belief that
patient safety would be compromised. A recent large retro-
spective database study7 concluded that patients who arrive
in the intensive care unit (ICU) after coronary artery surgery
with a temperature36°C are at significantly increased risk
of death, excessive bleeding, and other complications com-
pared with normothermic patients. Complete rewarming of
patients who have been cooled to 34°C requires either
rewarming of the blood in the pump oxygenator to temper-
atures 38°C, which may be detrimental to the brain,8 or
rewarming slowly and prolonging CPB time, which is also
associated with adverse effects. In weighing the risks and
benefits of a temperature management strategy for CPB, it is
essential to have an unbiased estimate of the consequences
of not completely rewarming the patient. We have recently
completed a randomized clinical trial of the neuroprotective
effect of mild hypothermia for patients undergoing coronary
artery bypass grafting (CABG).9 Our results suggest that
mild hypothermia decreases the incidence and severity of
cognitive deficits. This is the only trial in which hypother-
mia was extended into the postoperative period, and there
was no clinically important difference in bleeding or other
safety outcomes between the hypothermic and control
groups. However, both groups were hypothermic on arrival
in the ICU: 35.3°C  0.6°C and 33.6°C  0.5°C (mean 
SD). In the present trial, we have been able to maintain
constant temperature throughout the operative period until
arrival in ICU: normothermia in the control group and 34°C
in the hypothermic group. This provided a unique opportu-
nity to explore the safety of mild hypothermia versus true
normothermia in comparable groups of cardiac surgical
patients. We present here an analysis of our safety data and
a comparison of our results with the published literature. We
believe that these data can help those caring for cardiac
surgical patients to make a more informed decision about
the optimal temperature management for their patients.
Materials and Methods
Patients
Between October 2000 and October 2002, patients older than 60
years who were scheduled to undergo nonemergency coronary
artery surgery at the University of Ottawa Heart Institute were
asked for informed consent for enrollment in this trial, which was
approved by our institutional review board. Because the primary
outcome of the trial was postoperative cognitive function, we
excluded patients with neurological deficits. Patients with serum
creatinine more than twice normal and those with a history of
cardiac surgery were also excluded. At the time of the safety data
analysis presented here, 144 patients had been studied.
Protocol and Randomization
Anesthesia was induced with midazolam and sufentanil and main-
tained with isoflurane, as well as with sufentanil and midazolam or
propofol infusions. All patients were monitored with a radial
arterial line and pulmonary artery catheter. After the induction of
anesthesia, a temperature probe was placed in the nasopharynx,
and this temperature was monitored and controlled throughout the
intraoperative period. Bladder temperature was used as an indica-
tor of visceral temperature. Tranexamic acid (1-g bolus after
induction and a 2.0 mg/kg/h intraoperative infusion) was admin-
istered to all patients.
Eligible and consenting patients were equally assigned to hy-
pothermia or normothermia by using a computer-generated ran-
domization list. The randomization was stratified according to age
75 years, and blocks of 8 were used. Treatment assignment was
concealed in opaque sealed envelopes that were assigned sequen-
tially as patients were enrolled, according to age block. The study
coordinator opened the envelope 30 minutes before operation.
Patients were unaware of the treatment assignment, which was not
concealed from the clinical staff. Patients in the normothermic
group were warmed with a forced-air heating blanket for 15 to 30
minutes before entering the operating room. On arrival in the
operating room, high-efficiency thermal pads were applied to the
patient’s back and posterior aspect of the upper leg. The pads were
connected to a water-circulating thermal control system (Arctic
Sun; Medivance Corporation, Louisville, Colo), and cooling to
34°C or warming to 37°C was begun. Patients were kept as close
as possible to nasopharyngeal temperatures of 37°C or 34°C
throughout the intraoperative period. CPB was performed via an
ascending aortic cannula and a 2-stage right atrial cannula with
membrane oxygenators and 43-m arterial line filters (Cobe Car-
diovascular, Arvada, Colo) with a nonpulsatile flow at 2.5 to 2.8
L/min/m2. Mean arterial pressure was maintained between 50 and
80 mm Hg by using phenylephrine or isoflurane. Blood gases were
not temperature corrected. The heater/cooler was needed only to
make small corrections in temperature during CPB; the tempera-
ture of blood leaving the oxygenator was monitored and recorded
and was not allowed to exceed 37.5°C or 34.5°C in the normo-
thermic and hypothermic groups, respectively. After application of
the aortic crossclamp, cardiac arrest was induced and maintained
with antegrade cold crystalloid cardioplegia. Proximal anastomo-
ses were fashioned by using a side-biting clamp on the aorta.
Nasopharyngeal temperatures were kept constant at 34°C or 37°C
until arrival in the ICU. In the ICU, forced-air warming blankets
were applied. The transfusion protocol conformed with the guide-
lines at our institution, which are to ensure that hematocrit is
20% before separating the patient from CPB. After CPB and in
the ICU, hematocrit is maintained 24%. Guidelines for reopen-
ing were blood loss 500 mL in 1 hour or 1000 mL in 4
consecutive hours. Inotropes were used if the cardiac index was
less than 2.2 L/min/m2 in the presence of adequate preload. Pa-
tients were extubated if they were responsive and hemodynami-
cally stable, temperature was 36°C, chest tube drainage was
100 mL/h, PAO2 was 80 mm Hg on FIO2 50%, pH was 7.3,
PCO2 was 50 on continuous positive airway pressure of 8 cm
H2O and pressure support of 10 cm H2O, respiratory rate was25
breaths/min, and tidal volume was 5 mL/kg. To be discharged
from the ICU, patients had to be off all vasoactive drug infusions,
Nathan et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 127, Number 5 1271
CS
P
have SpO2 90% with 50% oxygen by mask, have a respiratory
rate of 10 to 25 breaths/min, have chest tube drainage 50 mL/h,
and have urine output 0.5 mL/kg/h. Criteria for discharge from
the hospital included the ability to tolerate a light diet and to
ambulate 120 m and 9 stairs with no more than a 30-beat/min
increase in HR, and SpO2 90%.
Outcomes
During surgery, we recorded nasopharyngeal, bladder, and oxy-
genator outlet temperatures, the use of blood products and inotro-
pic drugs, time on CPB, and aortic crossclamp time. The quantity
of phenylephrine and Ringer’s lactate administered during CPB
was measured. Bleeding from the chest and mediastinal tubes was
measured hourly during the first 12 postoperative hours. The use of
blood products and inotropes after surgery was also recorded.
Time until extubation, days in the ICU, and days in the hospital
were noted. Electrocardiograms taken 2 hours, 1 day, and 2 to 5
days after surgery were assessed. Myocardial infarction was de-
fined as the appearance of new Q waves0.04 seconds in duration
in at least 2 contiguous leads. Creatine kinase (CK) was measured
on the morning after surgery. Troponin T was determined if the
total CK was greater than 900 U/L. Chest and leg wound infections
were documented by the infection control service by using estab-
lished definitions.10
Statistical Analysis
The primary analysis was by treatment group (normothermia or
hypothermia), with no exclusions. All patients received the as-
signed treatment. These data are based on a midpoint safety
analysis of a trial of the neuroprotective effect of mild hypother-
mia. The sample size for the full trial is 300 analyzable cases. A
sample size of 150 provides 80% power (with   .05) to detect
a difference in 12-hour postoperative chest tube losses of 250 mL
on the basis of the SD from our previous study9 of 542 mL. Data
are presented as mean  SD or median  interquartile range.
Continuous variables were compared by using unpaired t tests if
normally distributed or the Mann-Whitney test otherwise. Cate-
gorical data were compared by using a 2 test or the Fisher exact
test when an expected cell value was 5.
Results
The preoperative characteristics (Table 1) of the 73 patients
randomly assigned to normothermia and the 71 assigned to
hypothermia were similar. At the time of aortic cannulation,
the normothermic group was 0.7°C below the target tem-
perature, and the hypothermic group was 0.5°C above the
target (Table 2). The target temperatures were achieved
soon after the initiation of CPB. At the end of CPB, both
groups were at the target temperatures, and there was no
gradient between nasopharyngeal and bladder temperature.
On arrival in the ICU, the temperature was the same at all
sites and was within 0.3°C of the target in both groups.
There was no clinically important difference in intraopera-
tive use of allogeneic packed red blood cells or inotrope
infusions. No patient required the use of the intra-aortic
balloon pump. More phenylephrine was required to main-
tain mean arterial pressure in the normothermic group. The
hypothermic group received more crystalloid during CPB.
Postoperative (Table 3) safety outcomes were similar be-
tween groups. The mean difference in 12-hour postopera-
tive blood loss between groups was 70 mL, with a 95%
confidence interval including the hypothermic group losing
196 mL more to 56 mL less blood than the normothermic
group. Blood product use was nearly identical. Two patients
from each group returned to the operating room for exces-
sive bleeding. Within 4 hours of arrival in the ICU, 90% of
patients in the hypothermic group had rewarmed to 36°C.
During the first 12 hours in the ICU, there was no significant
difference between groups in the frequency of use of ino-
tropes or nitroprusside. There were 4 patients with Q-wave
myocardial infarctions (2 in each group). Creatinine kinase
levels were 673  564 IU and 524  276 IU in the
normothermic and hypothermic groups, respectively (P 
.42; Mann-Whitney test). There was a bimodal distribution
of CK; 14 patients in the normothermic group and 4 in the
hypothermic group had levels 900 U/L (P  .015; 2
test). Troponin T was determined in these patients (mean 
SD: normothermic, 0.74  0.46 ng/mL; hypothermic, 0.67
 0.13 ng/mL; P  .915). The length of ICU stay was 8.4
hours less in the hypothermic group. Wound infections
developed in 3 patients within 30 days of operation: 2 in the
normothermic group and 1 in the hypothermic group. There
were 2 deaths in the hospital, both in the hypothermic group
and both on the day of operation. The probable cause of
death in 1 patient was cardiogenic shock due to a periop-
erative myocardial infarction. The other patient became
hypotensive and was reopened but could not be resuscitated.
Both patients had temperatures 36°C before becoming
hemodynamically unstable.
TABLE 1. Preoperative characteristics of the patients*
Characteristic
Normothermic
(n  73)
Hypothermic
(n  71)
Age (y) 70 7 68 6
Male sex 61 (84) 64 (90)
Left ventriclar ejection fraction 35% 61 (84) 64 (90)
CCS
1 and 2 23 (32) 21 (30)
3 31 (43) 36 (51)
4 19 (26) 14 (20)
NHYA
I 65 (89) 62 (87)
II 5 (7) 6 (8)
III 3 (4) 3 (4)
Diabetes mellitus
Diet or oral medication 25 (35) 17 (23)
Insulin 3 (4) 5 (7)
CCS, Canadian Cardiovascular Society angina classification; NYHA, New
York Heart Association functional classification.
*Data are mean  SD or n (%).
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Discussion
In patients undergoing CABG surgery who were randomly
assigned to a constant intraoperative temperature of 34°C or
37°C, we found no clinically important effect of tempera-
ture management on perioperative complications. These
results support the finding of our previous series of 223
patients, in which a 2°C to 3°C temperature difference had
no effect on morbidity or mortality.9 In the previous study,
on arrival in the ICU both groups were mildly hypothermic,
with a mean temperature of 35.3°C in the control group and
33.6°C in the hypothermic group. In this study, true nor-
mothermia was maintained in the control group and proved
to confer no advantage to the patients. The fact that intra-
operative hypothermia extending into the postoperative pe-
riod did not have a significant effect on blood loss or blood
product use indicates that temperature in the range mea-
sured, in this patient population, does not have an important
effect on postoperative bleeding. All patients received tran-
examic acid, and this may account for the fact that blood
loss in both groups was approximately 200 mL less than in
our previous study. There was no increase in time to extu-
bation associated with hypothermia, although these results
may not apply to institutions desiring earlier extubations.
The fact that 90% of the hypothermic patients had temper-
atures 36°C within 4 hours of arrival in the ICU suggests
that rewarming need not delay extubation beyond 4 hours in
most patients. Time spent in the ICU was 9.6 hours, or 24%,
shorter in the hypothermic group. We have no explanation
for this difference. Hospital length of stay was the same for
both groups. This study was not powered to demonstrate a
difference in wound infection rate or myocardial infarction;
to show a difference between 5% in 1 group compared with
7.5% in the other, with an  of .05 and a power of 80%,
would require 1549 patients per group. It is difficult to
interpret the importance of enzyme release after cardiac
surgery. In a recent study, Januzzi and associates11 found
that patients without cardiac complications after cardiac
surgery had mean  SD troponin T levels of 0.89  0.75
ng/mL 18 to 24 hours after surgery, compared with 8.43 
9.10 ng/mL in patients with complications. Mean troponin T
levels were 0.89 ng/mL in both groups in this study;
however, because myocardial-specific enzyme results were
available in only a few patients, it is impossible to interpret
the results with confidence. The incidence of Q-wave myo-
cardial infarction was not different between groups.
The association between hypothermia and adverse out-
come is most evident in trauma, where injured patients
presenting to the emergency room with temperatures of
TABLE 2. Operative characteristics*
Characteristic
Normothermic
(n  73)
Hypothermic
(n  71) P value
Cardiopulmonary bypass time
(min)
77 19 73 19 .30
Aortic crossclamp time (min) 45 14 44 15 .70
Coronary artery bypass grafts 3 0.7 3 0.6 .18
Glucose† (mmol/L) 7 1.5 7 1.2 .22
Hematocrit† 25 4.1 25 3.6 .92
Patients receiving
intraoperative allogeneic
red blood cells
7 (9.6%) 4 (5.6%) .37
Phenylephrine during CPB
(mg)‡
2.0 (2.6) 0.5 (1.1) .001
Ringer’s lactate on CPB (L) 2.67 0.74 2.96 0.68 .015
Nasopharyngeal temperature
at aortic cannulation (°C)
36.3 0.43 34.5 0.60 .0001
Nasopharyngeal temperature
at start of cardiopulmonary
bypass (°C)
36.3 0.45 34.3 0.60 .0001
Bladder temperature at start
of cardiopulmonary bypass
(°C)
36.4 0.40 35.0 0.66 .0001
Nasopharyngeal temperature
at end of cardiopulmonary
bypass (°C)
37.0 0.17 34.1 0.13 .0001
Bladder temperature at end of
cardiopulmonary bypass
(°C)
37.0 0.15 34.1 0.19 .0001
Inotrope infusions 6 (8%) 3 (4%) .49
Temperature on arrival in ICU
(°C)§
36.7 0.38 34.3 0.38 .0001
CPB, Cardiopulmonary bypass; ICU, intensive care unit.
*Data are mean  SD or n (%) unless otherwise noted.
†Measured after protamine administration; 1 mmol/L  18.02 mg/dL.
‡Median (interquartile range).
§Temperatures were equal at all sites by the time of arrival in the ICU.
TABLE 3. Safety outcomes*
Outcome
Normothermic
(n  73)
Hypothermic
(n  71) P value
Hours ventilated in ICU 10.9 8.4 11.0 7.8 .93
Days in ICU 1.56 1.1 1.21 0.7 .02
Median 1.07 0.98 .014
Days in hospital 6.5 3.3 6.3 2.2 .65
Median 5.0 5.0
12-h blood loss in ICU (mL) 596 356 666 405 .28
Blood utilization in ICU
Allogeneic red blood cells (U) 0.7 1.4 0.7 1.2 .76
Number of patients (%) 23 (32) 24 (34) .77
Fresh frozen plasma (U) 0.2 0.9 0.4 1.2 .38
Number of patients (%) 3 (4) 5 (7) .44
Platelets (U) 0.1 0.9 0.1 0.7 .87
Number of patients (%) 1 (1.4) 1 (1.5) .98
Any blood product
Number of patients (%) 25 (34) 29 (41) .41
Reopened for bleeding (%) 2 (2.7) 2 (2.9) 1.0
Inotrope use (%) 16 (22) 11 (15) .32
Nitroprusside (%) 29 (40) 31 (44) .63
Mortality (%) 0 (0) 2 (3) .23
ICU, Intensive care unit.
*Data are mean  SD unless otherwise noted.
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32°C have a mortality of 100%.12 Despite laboratory
evidence of a possible benefit of hypothermia in shock,13 a
randomized study of delayed rewarming in trauma patients
demonstrated increased fluid requirements in the hypother-
mic group and an increased early mortality.14 Sessler1 has
comprehensively reviewed the adverse effects of mild peri-
operative hypothermia. These include increased incidence
of wound infection, increased bleeding, cardiac events, de-
layed recovery from anesthesia, postoperative shivering,
and thermal discomfort. Schmied and colleagues15 random-
ized patients undergoing hip surgery to active warming or
conventional treatment. The warmed patients left the oper-
ating room at a temperature of 36.6°C, compared with
35.0°C in the control patients. Perioperative blood loss was
25% less in the normothermic group. This is supported by
laboratory evidence of prolongation of coagulation factor
kinetics16,17 and platelet dysfunction18 with hypothermia.
Kurz and colleagues19 and Melling and associates20 have
published randomized controlled trials demonstrating a re-
duced incidence of wound infection with warming in pa-
tients undergoing clean-contaminated or clean operation,
respectively. The increased susceptibility to wound infec-
tion may be due to decreased tissue oxygen tension second-
ary to cutaneous vasoconstriction in response to hypother-
mia.21 Frank and associates22 provide evidence of an
increased incidence of cardiac events after major operation
in patients with proven ischemic heart disease or at high risk
of ischemic heart disease in whom mild hypothermia was
allowed to develop. Unlike the study of Frank and associ-
ates, patients in this study were revascularized.
There are no studies, other than the present research, that
randomize cardiac surgical patients to perioperative hypo-
thermia compared with normothermia. There are numerous
studies of the effects of differing temperatures confined to
the period during which the patient is on CPB. Of 6 studies
that reported perioperative blood loss, 5 studies23-27 found
no difference, and 1 study28 showed increased loss in the
hypothermic group. The Cochrane Library5 recently pub-
lished a review of 17 randomized controlled trials compar-
ing hypothermia and normothermia during CPB. They
found a trend for a reduced incidence of stroke in the
hypothermic group and a trend for increased non–stroke-
related perioperative deaths in the hypothermic group.
When all bad outcomes were considered (cardiac and neu-
rological), there was no difference related to temperature.
The only publication reporting the effect on outcome of
postoperative hypothermia in cardiac surgical patients is a
large retrospective database analysis including 5701 pa-
tients undergoing isolated CABG.7 Patients arriving in the
ICU with temperatures 36°C were considered hypother-
mic. After adjusting for severity of illness and intraoperative
risk factors, it was found that the normothermic group had
a significantly lower risk for death (odds ratio, 0.59; 95%
confidence interval, 0.39-0.91) and transfusion (odds ratio,
0.61; 95% confidence interval, 0.54-0.69). Duration of me-
chanical ventilation and ICU and hospital length of stay
were all increased in the hypothermic patients. The results
of this retrospective study are in contrast with the results of
the present study and our previous study.9 Only a random-
ized trial can generate comparable groups in which both
known and unknown prognostic factors are balanced. In our
previous study, we were unable to prevent cooling of pa-
tients after separation from CPB, and patients arrived in the
ICU with temperatures ranging from 32.6°C to 35.3°C in
the hypothermic group and 33.6°C to 36.5°C in the control
group. Although mean blood loss in the 2 groups was not
significantly different (control, 812  493 mL; hypother-
mic, 858 592 mL; mean SD; P .53), this distribution
of temperatures allowed us to perform multiple-regression
analysis to identify factors that might explain the dispersion
of temperatures among patients randomly assigned to the
same group. We found that the patients from our previous
study, who arrived in the ICU with temperatures most below
the rewarming target, were more likely to have had a
prolonged CPB time and more blood transfusions (fluid
warmers were not used in Insler and associates’7 study or
our previous study). It is possible that patients with lower
temperatures on arrival in the ICU in Insler and associates’
study were those in whom surgical difficulties were encoun-
tered that prolonged operation or resulted in increased
bleeding. These difficulties may have been the true cause of
the poor outcomes. Thus, postoperative hypothermia may
have been a correlate of poor outcome, but not the cause.
Rapid rewarming before terminating hypothermic CPB
requires heating the blood in the oxygenator to 39°C.29
The brain rapidly warms to the temperature of the blood,
and the resulting cerebral hyperthermia is generally be-
lieved to be injurious.8 Avoiding heating the blood to tem-
peratures 37°C to 38°C would necessitate prolonged re-
warming times if body temperature is to be restored to
37°C. If mild perioperative hypothermia is safe, then pa-
tients need not be completely rewarmed before separating
from CPB, and the deleterious effects of cerebral hyperther-
mia, as well as prolonged CPB, can be avoided. This strat-
egy would become even more compelling if our recent
findings of a neuroprotective effect of extended mild hypo-
thermia for patients undergoing CABG were confirmed.9
The present research is the only randomized trial com-
paring hypothermia with normothermia throughout the en-
tire intraoperative period in patients undergoing coronary
artery surgery. Our data support the safety of perioperative
mild hypothermia in patients undergoing elective nonreop-
erative coronary artery surgery with CPB.
We gratefully acknowledge the expert assistance of Denise
Wozny and Geri Wells.
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